The Enterprise Value as of December 2025 (TTM) for Jupiter Neurosciences, Inc. (JUNS) is 41.51M

According to Jupiter Neurosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 41.51M. This represents a change of -59.86% compared to the average of 103.41M of the last 4 quarters.

Jupiter Neurosciences, Inc. (JUNS) Historical Enterprise Value (quarterly & annually)

How has JUNS Enterprise Value performed in the past?

The mean historical Enterprise Value of Jupiter Neurosciences, Inc. over the last ten years is 136.49M. The current 41.51M Enterprise Value has changed 2.94% with respect to the historical average. Over the past ten years (40 quarters), JUNS's Enterprise Value was at its highest in in the December 2024 quarter at 304.43M. The Enterprise Value was at its lowest in in the September 2020 quarter at 0.

Jupiter Neurosciences, Inc. (JUNS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Jupiter Neurosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Jupiter Neurosciences, Inc. (JUNS) Average Enterprise Value

How has JUNS Enterprise Value performed in the past?

The current Enterprise Value of Jupiter Neurosciences, Inc. (JUNS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Jupiter Neurosciences, Inc. (JUNS) Enterprise Value vs. Peers

How is JUNS’s Enterprise Value compared to its peers?

Jupiter Neurosciences, Inc.’s Enterprise Value is greater than Skye Bioscience, Inc. (15.30M), greater than Serina Therapeutics, Inc. (31.15M), greater than Aligos Therapeutics, Inc. (26.21M), greater than ABVC BioPharma, Inc. (37.86M), greater than X4 Pharmaceuticals, Inc. (6.31M), greater than Kezar Life Sciences, Inc. (20.85M), less than FibroGen, Inc. (103.14M), greater than Genenta Science S.p.A. (32.92M), less than Mersana Therapeutics, Inc. (83.22M), greater than Grace Therapeutics, Inc. (29.50M),

Build a custom stock screener for Jupiter Neurosciences, Inc. (JUNS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Jupiter Neurosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Jupiter Neurosciences, Inc. (JUNS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Jupiter Neurosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.